Clinical Trial Update: Use of the Guardian™ Connect System With Smart Connected Devices [NA]

View source ↗

Summary

The study evaluated the Guardian Connect System with Smart Connected Devices for Type 1 Diabetes Mellitus. It has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Guardian Connect System

Snippet

Sponsor: Medtronic MiniMed, Inc. | Conditions: Type 1 Diabetes Mellitus | NA | Status: COMPLETED | Results posted: 2024-12-10